Xiangmin Cui - Nov 9, 2023 Form 4 Insider Report for ALPINE IMMUNE SCIENCES, INC. (ALPN)

Signature
/s/ Xiangmin Cui
Stock symbol
ALPN
Transactions as of
Nov 9, 2023
Transactions value $
$4,687,500
Form type
4
Date filed
11/14/2023, 05:33 PM
Previous filing
Jan 5, 2023
Next filing
Jan 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALPN Common Stock Purchase $4.69M +375K +27.56% $12.50 1.74M Nov 9, 2023 See Footnote F1
holding ALPN Common Stock 5.35M Nov 9, 2023 See Footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reportable securities are owned directly by Decheng Capital Global Healthcare Fund (Master), LP ("Healthcare"). The Reporting Person is the indirect managing member and ultimate beneficial owner of Decheng Capital Global Healthcare GP, LLC, the general partner of Healthcare. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein.
F2 The reportable securities are owned directly by Decheng Capital China Life Sciences USD Fund III, L.P. ("Fund III"). The Reporting Person is the manager of Decheng Capital Management III (Cayman), LLC, the general partner of Fund III. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein.